T
TransCode Therapeutics, Inc. (RNAZ)
NCM – Real Time Price. Currency in USD
6.73
-0.27 (-3.86%)
At close: May 12, 2026, 4:00 PM EDT
7.02
+0.29 (4.33%)
After-hours: May 12, 2026, 5:08 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
6.73
-0.27 (-3.86%)
At close: May 12, 2026, 4:00 PM EDT
7.02
+0.29 (4.33%)
After-hours: May 12, 2026, 5:08 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Cash reserves $17.8M barely cover the upcoming debt maturities $0.0
Total current assets $22.0M exceed Total current liabilities $3.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest coverage ratio (-13,356.8x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$8.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.29 | 6.05 | 10 | |
| Quick ratio | 6.29 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | -13356.83 | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -99K | -517K | -535K | -114K | -114K |
| Operating Income | -19M | -19M | -16M | -19M | -19M |
| Net Income | -18M | -19M | -17M | -35M | -35M |
| EBITDA | -19M | -19M | -15M | -19M | -19M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | -100 | 25 | 5.5 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -176.82 | N/A | -99.56 | 3.3 |
| Y/Y | 999 | -127.22 | N/A | -158.94 | 3.3 |
| 3y average | 999 | -34.25 | N/A | -11.34 | 3.3 |
| 5y average | 999 | -90.27 | N/A | -275.45 | 3.3 |
| Weighted average score | 3.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |